Neuren Pharmaceuticals Limited
NURPF
$10.97
-$1.31-10.67%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -2.75% | 1,600.06% | 0.20% | -92.60% | -0.47% |
Total Depreciation and Amortization | -2.70% | 2.78% | 0.00% | 0.00% | 0.00% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -2.75% | 925.45% | -0.21% | -129.10% | -0.47% |
Change in Net Operating Assets | 2.75% | -396.70% | -0.21% | -203.18% | -0.47% |
Cash from Operations | -2.75% | 145.88% | -0.21% | -114.80% | -0.47% |
Capital Expenditure | 0.00% | -130.00% | 0.00% | 86.11% | 0.00% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -2.75% | 298.09% | 0.22% | 100.52% | 0.47% |
Cash from Investing | -2.75% | 298.70% | 0.22% | 100.52% | 0.47% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -100.00% | 0.00% | -34.47% | 0.00% |
Repurchase of Common Stock | 0.00% | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | 100.00% | 0.00% | 18.18% | 0.00% |
Cash from Financing | 2.75% | -742.08% | 0.20% | -33.94% | -0.47% |
Foreign Exchange rate Adjustments | 2.75% | -144.81% | 0.21% | 1,021.10% | -0.48% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -2.77% | 104.08% | -0.21% | 31.18% | 0.47% |